Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of LSR Group recommended dividends

3/15/24 LSRG

Lenta doubled the number of Zoomarkets

3/15/24 LENT

UTair passenger traffic on airplanes increased by 13% in January-February

3/15/24 UTAR

Rusal made an advance payment for a stake in HWNM

3/15/24 RUAL

Globaltrans completes redomiciliation in Abu Dhabi

3/15/24 GLTR

Tatneft reported for 2023 by IFRS

3/15/24 TATN

Board of Directors of Positive Technologies Group recommended dividends

3/15/24 POSI

Seligdar and Rosgeologiya implement junior projects in Yakutia

3/15/24 SELG

TRK reported for 2023 by IFRS

3/15/24 TORS

NCSP handled more than 60,000 TEU in February

3/15/24 FESH